Thursday, April, 18, 2019 09:19:09

Sun Pharma’s SPARC inks a research collaboration deal with HitGen

The research collaboration pact is aimed at identifying unique small molecule leads for targets of interest HitGen would apply its high-grade technology platform to find unique leads for SPARC Sun Pharma Advanced Research Company (SPARC), the research arm of India-based multinational drug manufacturer Sun Pharmaceutical …

Precision for Medicine acquires SimplicityBio to add AI to QuartzBio™

A business unit of Precision Medicine Group, Precision for Medicine, has hit the headlines for announcing the acquisition of SimplicityBio, extending artificial intelligence capabilities to its QuartzBio™, a multiomic informatics and data integration platform. According to sources close to the development, the introduction of an …

GeoVax, Leidos to develop malaria vaccines under extended partnership

As a part of an expanded collaboration, GeoVax Labs Inc., an American biotechnology company and Leidos Inc., a scientific research company, have reportedly announced the development of malaria vaccine candidates. The USAID (United States Agency for International Development) MVDP (Malaria Vaccine Development Program) is reported …

TLC and 3SBio partner to commercialize two NanoX products in China

A clinical-stage specialty pharmaceutical company Taiwan Liposome Company Ltd. and 3SBio Inc, China’s leading biopharmaceutical company have reportedly  entered into an exclusive partnership intended to commercialize two liposomal products in China, using TLC’s proprietary NanoX technology platform. As per the alliance, TLC and 3SBio will …

U.S. FDA grants Fast Track designation for Iovance’s LN-145 therapy

With the Fast Track designation, Iovance is likely to increase the frequency of its communication with the U.S. FDA. Reputed biotechnology company Iovance Biotherapeutics, Inc., has reportedly been granted the Fast Track designation for its adoptive cell therapy LN-145, developed using its proprietary TIL manufacturing …